|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
STOCK APPRECIATION RIGHTS | (5) | 07/11/2018 | M | 2,724 | (6) | (7) | COMMON STOCK | 2,724 | $ 25.67 | 2,724 | D | ||||
STOCK APPRECIATION RIGHTS | (8) | 07/11/2018 | M | 1,362 | (9) | (10) | COMMON STOCK | 1,362 | $ 45.36 | 1,362 | D | ||||
STOCK APPRECIATION RIGHTS | (11) | 07/11/2018 | M | 1,603 | (12) | (13) | COMMON STOCK | 1,603 | $ 43.92 | 1,603 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
BERCE DANIEL E ONE MUSEUM PLACE, SUITE 500 3100 WEST 7TH STREET FORT WORTH, TX 76107 |
X |
/s/ Tara D. Mackey, attorney-in-fact for Daniel E. Berce | 08/09/2018 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Shares forfeited for the conversion of stock appreciation rights ("SARs"), which are settled in shares of AZZ common stock in an amount equal to the excess value of the grant date price ($25.67) over the exercise price ($54.85). |
(2) | Shares forfeited for the conversion of SARs, which are settled in shares of AZZ common stock in an amount equal to the excess value of the grant date price ($45.36) over the exercise price ($54.85). |
(3) | Shares forfeited for the conversion of SARs, which are settled in shares of AZZ common stock in an amount equal to the excess value of the grant date price ($43.92) over the exercise price ($54.85). |
(4) | The shares sold on the open market are the aggregate net shares received upon the exercise of the SARs reported in Table I. |
(5) | The conversion of stock appreciation rights ("SARs"), which are settled in shares of AZZ common stock in an amount equal to the excess value of the grant date price ($25.67) over the exercise price ($54.85). |
(6) | On March 1, 2012 the reporting person was granted SARs, which vested ratably over a 3-year period beginning on March 1, 2013. |
(7) | The SARs granted on March 1, 2012 have an expiration date of March 1, 2019. |
(8) | The conversion of SARs, which are settled in shares of AZZ common stock in an amount equal to the excess value of the grant date price ($45.36) over the exercise price ($54.85). |
(9) | On March 1, 2013 the reporting person was granted SARs, which vested ratably over a 3-year period beginning on March 1, 2014. |
(10) | The SARs granted on March 1, 2013 have an expiration date of March 1, 2020. |
(11) | The conversion of SARs, which are settled in shares of AZZ common stock in an amount equal to the excess value of the grant date price ($43.92) over the exercise price ($54.85). |
(12) | On March 1, 2014 the reporting person was granted SARs, which vested ratably over a 3-year period beginning on March 1, 2015. |
(13) | The SARs granted on March 1, 2014 have an expiration date of March 1, 2021. |
Remarks: This Form 4 was amended to correct the aggregate number of shares forfeited to pay the conversion price of the underlying SARs. |